ACI
ABMD

AMP Capital Investors’s Abiomed Inc ABMD Stock Holding History

AMP Capital Investors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,636
Closed -$3.46M – 1059
2021
Q3 		$3.46M Sell
10,636
-7,126
-40% -$2.41M 0.02% 635
2021
Q2 		$5.54M Sell
17,762
-1,380
-7% -$423K 0.03% 579
2021
Q1 		$6.08M Sell
19,142
-889
-4% -$285K 0.03% 543
2020
Q4 		$6.49M Buy
20,031
+4,396
+28% +$1.22M 0.03% 512
2020
Q3 		$4.26M Buy
15,635
+423
+3% +$122K 0.03% 577
2020
Q2 		$3.65M Buy
15,212
+1,709
+13% +$343K 0.02% 588
2020
Q1 		$2.01M Sell
13,503
-438
-3% -$72.7K 0.01% 656
2019
Q4 		$2.33M Sell
13,941
-11,751
-46% -$2.18M 0.01% 736
2019
Q3 		$4.52M Sell
25,692
-6,378
-20% -$1.38M 0.03% 569
2019
Q2 		$8.18M Sell
32,070
-18,582
-37% -$4.93M 0.05% 407
2019
Q1 		$14.4M Buy
50,652
+867
+2% +$288K 0.08% 269
2018
Q4 		$15.8M Sell
49,785
-2,796
-5% -$971K 0.1% 230
2018
Q3 		$23.3M Buy
52,581
+10,273
+24% +$4.05M 0.13% 198
2018
Q2 		$17.3M Buy
42,308
+10,850
+34% +$3.93M 0.1% 241
2018
Q1 		$8.9M Buy
31,458
+16,159
+106% +$4.1M 0.05% 408
2017
Q4 		$2.87M Buy
15,299
+10,899
+248% +$2.03M 0.02% 690
2017
Q3 		$742K Buy
4,400
+1,300
+42% +$197K ﹤0.01% 939
2017
Q2 		$435K Buy
+3,100
New +$417K ﹤0.01% 1000
2015
Q3 		– Sell
-6,600
Closed -$431K – 1248
2015
Q2 		$431K Buy
+6,600
New +$439K ﹤0.01% 1004

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

AMP Capital Investors's ABMD Position: Q4 2021 in Review

AMP Capital Investors sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 10,636 shares — an estimated $3.46M sold.

AMP Capital Investors first reported a position in ABMD in Q2 2015 and held it in 19 quarters. The position peaked at $23.3M in Q3 2018. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • AMP Capital Investors reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • AMP Capital Investors sold 10,636 Abiomed Inc shares in Q4 2021, an estimated $3.46M.
  • AMP Capital Investors first reported a position in Abiomed Inc in Q2 2015 and held it in 19 quarters.
  • AMP Capital Investors's Abiomed Inc position peaked at $23.3M in Q3 2018.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.